ASTRO to host news briefings on top cancer research papers

NewsGuard 100/100 Score

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

News briefing 1

When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

  • Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
  • Additional, specialized radiation not necessary for some women after mastectomy.
  • Radiation after surgery reduces chance of melanoma returning.
  • What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?

 

Where: McCormick Place West, Room 176b/c or on the Web at https://www.astro.org/

News briefing 2

When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

  • Stereotactic radiotherapy stops lung cancer from growing in frail patients.
  • Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.

 

Where: McCormick Place West, Room 176b/c or on the Web at https://www.astro.org/

News briefing 3

When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

  • Adding proton therapy "boost" to X-ray radiation therapy reduces prostate cancer recurrences.
  • Proton therapy is well-tolerated in prostate cancer patients.

 

Where: McCormick Place West, Room 176b/c or on the Web at https://www.astro.org/

News briefing 4

When: Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

  • Shorter radiation course stops cancer growth in high-risk prostate cancer patients.
  • Shorter radiation course as effective as standard therapy for prostate cancer recurrence.

 

Where: McCormick Place West, Room 176b/c, or on the Web at https://www.astro.org/

How: To participate in the webcasts, click on the links above to view slides and listen to the audio of the conference live over the Internet.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DASH diet may lower the risk of cardiovascular disease in breast cancer survivors